irman CJ, Pawaskar MD, et al. Diabetes medication  satisfaction tool: a focus on treatment regimens. Diabetes Care 2009; 32: 51–53. 23 Kroenke K, Strine TW, Spitzer RL, Williams JB, Berry JT,  Mokdad AH. The PHQ-8 as a measure of current depression in the general population. J Aﬀ  ect Disord 2009; 114: 163–73. 24 Russell-Jones D, Cuddihy RM, Hanefeld M, et al. Eﬃ   cacy and safety  of exenatide once weekly versus metformin, pioglitazone, and sitagliptin used as monotherapy in drug-naive patients with type 2 diabetes (DURATION-4): a 26-week double-blind study. Diabetes Care 2012; 35: 252–58. 25 Pratley RE, Nauck M, Bailey T, et al. Liraglutide versus sitagliptin  for patients with type 2 diabetes who did not have adequate glycaemic control with metformin: a 26-week, randomised, parallel-group, open-label trial. Lancet 2010; 375: 1447–56. 26 Zinman B, Hoogwerf BJ, Durán García S, et al. The eﬀ  ect of adding